AS Stock Analysis: Amer Sports | NYSE
Leisure | NYSE, USA | Market Cap: 21.143m USD | 12M Return: -6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 119M
Qual. Beats: 1
Rev. Trend: 99.2%
Warnings
No concerns identified
Tailwinds
Seasonality 2.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Amer Sports, Inc. is a Helsinki-based global sporting goods company that designs, manufactures, and sells sports equipment, apparel, footwear, and accessories across Europe, the Americas, the Middle East and Africa, Greater China, and the Asia Pacific. It operates through three reporting segments: Technical Apparel, Outdoor Performance, and Ball & Racquet Sports, covering categories ranging from climbing, hiking, running, skiing, and snowboarding to tennis, baseball, basketball, golf, and other team and individual sports. As a multi-brand operator in the Apparel, Accessories & Luxury Goods sub-industry of Consumer Discretionary, the company pursues a portfolio strategy in which distinct brands target specific product niches and consumer segments rather than competing under a single label.
The companys product portfolio includes Arcteryx, PeakPerformance, Salomon, Atomic, Armada, Wilson, Louisville Slugger, DeMarini, EvoShield, and Atec. Distribution is omnichannel, spanning company retail stores, general sporting goods retailers, specialty stores, independently operated partner stores, distributors, and retailer-owned and third-party e-commerce platforms. This mix of wholesale and direct-to-consumer channels is typical of premium sporting goods companies and supports both broad market reach and brand-level control of pricing and merchandising.
Amer Sports was founded in 1950 and is headquartered in Helsinki, Finland. The company was previously named Amer Sports Management Holding (Cayman) Limited and adopted its current name in August 2023. It trades on the NYSE under the ticker AS and completed its initial public offering on February 1, 2024.
- Arcteryx same-store sales accelerate globally
- Wilson tennis demand lifts Ball & Racquet revenue
- China consumer recovery supports premium brand growth
| Net Income: 457.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.12 > 1.0 |
| NWC/Revenue: 18.81% < 20% (prev 17.86%; Δ 0.95% < -1%) |
| CFO/TA 0.07 > 3% & CFO 737.0m > Net Income 457.4m |
| Net Debt (1.17b) to EBITDA (1.18b): 1.00 < 3 |
| Current Ratio: 1.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (572.2m) vs 12m ago 2.63% < -2% |
| Gross Margin: 58.23% > 18% (prev 56.28%; Δ 1.94% > 0.5%) |
| Asset Turnover: 75.94% > 50% (prev 64.07%; Δ 11.88% > 0%) |
| Interest Coverage Ratio: 7.64 > 6 (EBIT TTM 768.1m / Interest Expense TTM 100.6m) |
| A: 0.13 (Total Current Assets 3.32b - Total Current Liabilities 1.99b) / Total Assets 10.0b |
| B: -0.01 (Retained Earnings -135.8m / Total Assets 10.0b) |
| C: 0.08 (EBIT TTM 768.1m / Avg Total Assets 9.27b) |
| D: 2.07 (Book Value of Equity 6.74b / Total Liabilities 3.25b) |
| Altman-Z'' = 3.56 = A |
| DSRI: 1.00 (Receivables 723.9m/561.4m, Revenue 7.04b/5.46b) |
| GMI: 0.97 (GM 56.28% / 58.23%) |
| AQI: 0.90 (AQ_t 0.52 / AQ_t-1 0.58) |
| SGI: 1.29 (Revenue 7.04b / 5.46b) |
| TATA: -0.03 (NI 457.4m - CFO 737.0m) / TA 10.0b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of July 30, 2026, the stock is trading at USD 36.06 with a total of 2,220,782 shares traded. Over the past week, the price has changed by +4.89%, over one month by +8.29%, over three months by +4.52% and over the past year by -5.95%.
Current recommended Stop Loss: 34.20 (which is 5.2% or 1.4 ATR below the current price).
Amer Sports has received a consensus analysts rating of 4.26. Therefore, it is recommended to buy AS.
- StrongBuy: 11
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 50.1 | 39% |
P/E Trailing = 45.3947
P/E Forward = 27.8552
P/S = 2.8516
P/B = 3.1351
P/EG = 0.8181
Revenue TTM = 7.04b USD
EBIT TTM = 768.1m USD
EBITDA TTM = 1.18b USD
Long Term Debt = 792.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 309.9m USD (from shortTermDebt, last quarter)
Debt = 1.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 856.1m
Net Debt = 1.17b USD (calculated: Debt 1.86b - CCE 683.7m)
Enterprise Value = 22.3b USD (21.1b + Debt 1.86b - CCE 683.7m)
Interest Coverage Ratio = 7.64 (Ebit TTM 768.1m / Interest Expense TTM 100.6m)
EV/FCF = 46.83x (Enterprise Value 22.3b / FCF TTM 476.5m)
FCF Yield = 2.14% (FCF TTM 476.5m / Enterprise Value 22.3b)
FCF Margin = 6.77% (FCF TTM 476.5m / Revenue TTM 7.04b)
Net Margin = 6.50% (Net Income TTM 457.4m / Revenue TTM 7.04b)
Gross Margin = 58.23% ((Revenue TTM 7.04b - Cost of Revenue TTM 2.94b) / Revenue TTM)
Gross Margin QoQ = 59.90% (prev 57.69%)
Tobins Q-Ratio = 2.23 (Enterprise Value 22.3b / Total Assets 10.0b)
Interest Expense / Debt = 5.42% (Interest Expense 100.6m / Debt 1.86b)
Taxrate = 29.23% (195.1m / 667.5m)
NOPAT = 543.6m (EBIT 768.1m * (1 - 29.23%))
Current Ratio = 1.66 (Total Current Assets 3.32b / Total Current Liabilities 1.99b)
Debt / Equity = 0.28 (Debt 1.86b / totalStockholderEquity, last quarter 6.74b)
Debt / EBITDA = 1.00 (Net Debt 1.17b / EBITDA 1.18b)
Debt / FCF = 2.46 (Net Debt 1.17b / FCF TTM 476.5m)
Total Stockholder Equity = 5.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.93% (Net Income 457.4m / Total Assets 10.0b)
RoE = 7.72% (Net Income TTM 457.4m / Total Stockholder Equity 5.92b)
RoCE = 11.43% (EBIT 768.1m / Capital Employed (Equity 5.92b + L.T.Debt 792.3m))
RoIC = 6.82% (NOPAT 543.6m / Invested Capital 7.97b)
WACC = 9.87% (E(21.1b)/V(23.0b) * Re(10.40%) + D(1.86b)/V(23.0b) * Rd(5.42%) * (1-Tc(0.29)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 93.76 | Cagr: 7.19%
[DCF] Terminal Value 73.21% ; FCFF base≈376.0m ; Y1≈431.0m ; Y5≈634.3m
[DCF] Fair Price = 10.92 (EV 7.53b - Net Debt 1.17b = Equity 6.35b / Shares 581.8m; r=9.87% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.78 | # QB: 1
Revenue Correlation: 99.16 | Revenue CAGR: 22.09% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.10 | Chg30d=+48.28% | Revisions=+80% | Analysts=13
EPS next Quarter (2026-09-30): EPS=0.38 | Chg30d=-3.16% | Revisions=-53% | Analysts=13
EPS current Year (2026-12-31): EPS=1.26 | Chg30d=+0.57% | Revisions=+84% | GrowthEPS=+30.0% | GrowthRev=+22.0%
EPS next Year (2027-12-31): EPS=1.57 | Chg30d=+0.17% | Revisions=+83% | GrowthEPS=+24.7% | GrowthRev=+14.2%
[Analyst] Revisions Ratio: +60% (up=45, down=10)